We would love to hear your thoughts about our site and services, please take our survey here.
I think next week will be a great week for NGG. It rose a lot over the course of last week and more importantly has consolidated its share price at a much higher level. Indeed after the big 50% rise on Tuesday it actually rose again each day for the rest of the week adding another 20% which now puts it into a whole new trading range. It all bodes well for next week.
This is a very quiet board after 2 days of big rises!
This is flying up. I am now being quoted 0.47p to buy.
Make that 0.39p to sell. This is moving fast again.
I cant buy again without going to a dealer but it is now 0.38p to sell. On the up.
I can now, it may have always been Selftrade doing what Selftrade does best. It has been poor this week.
I cant even buy this online at the moment
http://www.growthcompany.co.uk/recommendations/1602593/nextgen-group.thtml NextGen GroupSPECULATIVE BUY 16/02/2011 Ben Jaglom Reduce text size Decrease text size Increase text size Increase text size Print article Print Share this article Share Email article to a friend Email Biotech minnow NextGen Group (NGG) is hoping to grow profits through its specialist services. The AIM-quoted company, which has its operational hub in the US and a sales and administration team in the UK, specialises in biomarker discovery and the development of assays. Its divisions include assayexpress, a service for developing protein biomarker assays, testingexpress, a means of testing and validating samples in a biomarket study and discoveryexpress, a suite of methods and platforms for biomarker and drug target discovery. Growth Company Investor spoke to Klaus Rosenau, the German CEO and veteran of a number of German IT concerns. Enthusing that he has 'a lot of contacts' within the investment industry Rosenau remarked on the recent excitement in the AIM biotech sector. 'Biotech is taking off at the moment - this is because those analysing the market as a whole realise that now is probably the best time to jump on the train'. Regarding the future of the company Rosenua commented that having recently received £927,000 via Teilfonds Zeus, a Luxembourg based fund managed by the 'family trust management' company, the company has the cash needed to develop its intellectual property. NextGen, like many AIM biotech stocks has recently seen a flurry of activity since the success of Sareum, with the shares having risen 58.3 per cent today to its current price of 0.38p, partially driven by the intense speculation on message boards which have contributed towards the see-saw changes in the share price experienced by many AIM biotech stocks. As a result our recommendation on NextGen Group is on a fundamental and relatively long-term basis, not on the basis of hourly price fluctuations. With the sector as a whole currently experiencing a rerating we believe that NextGen's shares are an appropriate investment as a speculative buy for investors willing to take some risks on the sector, with NextGen in particular looking to have strong prospects operating in a relatively unexcting area of the biotech sector that has for a while been overlooked by many. As a result we rate the shares as a speculative buy, though the shares are strictly not for widows and orphans. Reduce text size Decrease text size Increase text size Increase text size Print article Print Share this article Share Email article to a friend Email Tags: Assays, Biomarket, German, NextGen, Penny shares, Testing Sector: Pharmaceuticals & Biotechnology Companies: NextGen Market cap: £27.2m PE Forecast: n/a Share price: 0.38p
http://www.growthcompany.co.uk/recommendations/1602593/nextgen-group.thtml
A cracking rise today. The fact that this still finished 50% up and didnt slump in the afternoon bodes well.
I think the fact that it has held at 0.38p for such a long time and that people arent selling is a good sign.
This has flown up again today. Can anyone give some information as to why and if anything is in the pipeline.
Is there buys at .71? This really flys in no time at all
What is the story here?
Cheers for the information. I was in briefly a few weeks ago but had to sell due to another share that had come on my radar. When funds allow though I want to get back in if the news hasnt come yet.
What happened to the news, a few weeks ago, that was supposedly around the corner? Was it all just a P & D?
Good article. As I thought yesterday CSB will get a lot of coverage over the weekend due to McKeon being on board and with yesterdays rise. This can only bode well for Monday which will hopefully be a similar day to yesterday, maybe not a 100%+ rise but a good rise all the same.
People got burned with PMG by being either too greedy or buying in far too late at inflated levels. If you are in here early you are already well up on your original investment, some could be 10x up. I am only in at 3.75p and I am still well up so far. If you are unsure what to do but want to stay in you can always be sensible and top slice and take some profits. This way you will edge your bets, for free, and you will still have a sizable chunk left if you want to see how it all pans out. The choice is yours.
This is rising again now, 4.8p now with buys nearly 5p.
Are you just in here today or have you been in here a long time?